A study of topiramate pharmacokinetics and tolerability in children with epilepsy
- 1 May 1999
- journal article
- clinical trial
- Published by Elsevier in Pediatric Neurology
- Vol. 20 (5) , 339-344
- https://doi.org/10.1016/s0887-8994(99)00011-9
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizuresNeurology, 1999
- Comparison of the Steady‐State Pharmacokinetics of Topiramate and Valproate in Patients with Epilepsy During Monotherapy and Concomitant TherapyEpilepsia, 1997
- Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsyEpilepsy Research, 1996
- Double‐Blind, Placebo‐Controlled Trial of Topiramate (600 mg Daily) for the Treatment of Refractory Partial EpilepsyEpilepsia, 1996
- Steady‐State Pharmacokinetics of Topiramate and Carbamazepine in Patients with Epilepsy During Monotherapy and Concomitant TherapyEpilepsia, 1996
- Double‐Blind, Placebo‐Controlled Trial of Topiramate as Add‐on Therapy in Patients with Refractory Partial SeizuresEpilepsia, 1996
- Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosagesNeurology, 1996
- Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosagesNeurology, 1996
- Comparative Pharmacokinetics of the Newer Antiepileptic DrugsClinical Pharmacokinetics, 1993
- Anticonvulsant O-alkyl sulfamates. 2,3:4,5-Bis-O-(1-methylethylidene)-.beta.-D-fructopyranose sulfamate and related compoundsJournal of Medicinal Chemistry, 1987